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The stem-cell leukemia (SCL, also known as TAL1) gene encodes a basic helix-loop-helix transcription factor that is
essential for the initiation of primitive and definitive hematopoiesis, erythrocyte and megakarocyte differentiation,
angiogenesis, and astrocyte development. Here we report that the zebrafish produces, through an alternative
promoter site, a novel truncated scl (tal1) isoform, scl-b, which manifests a temporal and spatial expression distinct
from the previously described full-length scl-a. Functional analysis reveals that while scl-a and -b are redundant for the
initiation of primitive hematopoiesis, these two isoforms exert distinct functions in the regulation of primitive
erythroid differentiation and definitive hematopoietic stem cell specification. We further demonstrate that differences
in the protein expression levels of scl-a and -b, by regulating their protein stability, are likely to give rise to their
distinct functions. Our findings suggest that hematopoietic cells at different levels of hierarchy are likely governed by a
gradient of the Scl protein established through temporal and spatial patterns of expression of the different isoforms.
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Introduction
On the basis of anatomic locations of development, time of
initiation, and cell type produced, vertebrate hematopoiesis
can be divided into primitive and deﬁnitive programs [1–3].
In mouse, the primitive, or ﬁrst, wave of hematopoiesis
initiates in the yolk sac at about embryonic day 7.5 and
produces primarily nucleated embryonic erythrocytes and
macrophages [4,5]. The deﬁnitive, or second, wave of
hematopoiesis is believed to originate from the intra-
embryonic aorta–gonads–mesonephros at approximately
embryonic day 8.5 and give rise to all the mature blood cell
types [6–8].
Similar to that of mammals, zebraﬁsh hematopoiesis also
consists of primitive and deﬁnitive programs, and produces
differentiated cells analogous to most of the mature blood
lineages found in mammals [9–11]. Zebraﬁsh primitive
erythropoiesis originates from the posterior lateral meso-
derm (PLM) as a pair of bilateral stripes at approximately the
ﬁve-somite stage [9,10,12]. These bilateral stripes extend
anteriorly and posteriorly, and converge in the midline at the
20-somite stage to form the main structure of the inter-
mediate cell mass (ICM), where the erythroid progenitors
further develop. On the other hand, primitive myelopoiesis is
believed to arise from the rostral blood island of the anterior
lateral mesoderm (ALM) region at around the ten-somite
stage, and produces mainly macrophages [10,13]. Compared
to the onset of primitive hematopoiesis, the onset of zebraﬁsh
deﬁnitive hematopoiesis is less well deﬁned. Preliminary
studies indicate that the earliest deﬁnitive hematopoietic
stem and progenitor cells arise from the ventral wall of dorsal
aorta (DA) at around 26 to 30 h postfertilization (hpf) and
subsequently migrate to the kidney, the adult hematopoietic
organ in zebraﬁsh, by 5 d postfertilization (dpf) [10,14,15].
Stem-cell leukemia (SCL, also known as TAL1) was originally
identiﬁed as a proto-oncogene through the study of T cell
acute lymphoblastic leukemia patients with a chromosomal
translocation at the breakpoint of t(1;14) (p32;q11) [16–18].
The importance of SCL in normal hematopoiesis and
angiogenesis was revealed by gene targeting analysis in mouse
embryonic stem cells. Mice lacking SCL function failed to
form vitelline vessels in the yolk sac and died at embryonic
day 8.5 of development because of the complete absence of
primitive hematopoiesis [19–21]. SCL-null embryonic stem
cells, when injected into blastocysts, failed to contribute to
any hematopoietic lineage in mouse chimeras [22,23]. These
results demonstrate that SCL is essential for the generation of
primitive and deﬁnitive hematopoietic cells as well as for the
formation of yolk sac vessels. In addition to its pivotal role in
early hematopoiesis, SCL also exerts important biological
functions in subsequent hematopoietic lineage speciﬁcation.
Enforced SCL expression in hematopoietic cell lines favors
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PLoS BIOLOGYerythroid differentiation [24,25], and ablation of SCL in adult
mice impairs erythropoiesis and megakarypoiesis [26,27].
Despite its important functions, the molecular mechanisms of
how SCL mediates these multiple functions remain obscure.
Previous in vitro studies in human and mouse malignant
hematopoietic cell lines have described several SCL isoforms
involved in T cell leukemia development and differentiation
of erythrocytes and megakaryocytes [28–33]. However, the
existence and biological functions of these SCL isoforms in
vivo have not been demonstrated.
In this study, we report that the zebraﬁsh produces,
through an alternative promoter site within exon 2, a novel
scl (tal1) isoform, scl-b, that encodes a truncated protein
lacking the N-terminal 118 amino acids (aa). Whole-mount in
situ hybridization (WISH) demonstrated that scl-b exhibits
temporal and spatial expression that overlaps but is clearly
distinctive from that of the full-length scl-a: scl-b emerges ﬁrst
and expresses in the entire ALM and PLM and the ventral
wall of DA, where the ﬁrst deﬁnitive hematopoietic progen-
itors arise; scl-a expresses later in the posterior of the ALM
and the PLM, possibly in a manner overlapping with scl-b, and
is subsequently restricted to the ICM region. Loss-of-function
analysis using an antisense morpholino oligonucleotide (MO)
knockdown approach revealed that while scl-a and -b are
redundant in the initiation of primitive hematopoiesis, these
two isoforms appear to function at different stages of
primitive erythroid cell differentiation. Analysis of deﬁnitive
hematopoiesis of scl-a and -b MO-injected embryos (mor-
phants) showed that the knockdown of Scl-b, but not Scl-a,
protein expression resulted in the loss of c-myb (cmyb) and
runx1 expression in the ventral wall of DA as well as rag1
expression in the thymus, demonstrating that scl-b but not scl-
a is essential for deﬁnitive hematopoietic stem cell develop-
ment. Interestingly, we found that scl-b and -a exhibited a
remarkable difference in their protein expression levels both
in vitro and in vivo, indicating that differences in the protein
expression level of scl-a and -b isoforms likely confer their
distinct functions in the regulation of hematopoietic cell
development.
Results
Identification of a Novel Zebrafish scl Isoform, scl-b
To investigate whether different scl isoforms exist in
zebraﬁsh, RNA samples were prepared from 18-somite-stage
embryos and kidney, the adult hematopoietic organ in
zebraﬁsh [10], and subjected to Northern blot analysis. The
result showed that two transcripts, one 2.6 kilobases (kb) and
the other 2.2 kb, were speciﬁcally hybridized to the probes
corresponding to the coding sequence and the 39 untrans-
lated region (UTR) of the zebraﬁsh scl cDNA (data not shown),
suggesting that the 2.6-kb and 2.2-kb transcripts may
represent two different scl isoforms. To characterize the
nature of these two transcripts, we carried out a rapid
ampliﬁcation of cDNA ends (RACE) experiment and obtained
one 39 RACE and two 59 RACE products (data not shown).
DNA sequencing revealed that the larger 59 RACE product
was identical to the published full-length scl sequence [34,35],
whereas the smaller fragment was also identical except that it
lacked the ﬁrst 438 base pairs at the 59 end of the full-length
scl, indicating that the 2.6-kb transcript is the full-length scl
and the 2.2-kb transcript represents a novel scl isoform. This
was conﬁrmed by Northern blot analysis, which showed that
while both transcripts were hybridized to the scl 39 UTR
probe (39-probe), only the larger 2.6-kb species was recog-
nized by the scl 59 414-bp probe (59-probe) (Figure 1A). We
hereafter designate the 2.6-kb full-length and the 2.2-kb
truncated forms as scl-a and scl-b, respectively. Time course
Figure 1. Identification of Zebrafish scl-b Isoform
(A) Northern blot analysis of scl expression in 3-h, 1- to 2-somite (s), 5- to
6-somite, 9- to 11-somite, 18-somite, and 2-dpf embryos and adult
kidney. The 39-probe (39 UTR) recognized both scl-a and -b isoforms
(middle), whereas the 59-probe (59 UTR) detected only the full-length scl-
a (top). ef1a was used as the loading control (bottom).
(B) Gene structures of scl-a and -b. scl-a consists of 4 exons (boxed
regions). scl-b transcript is initiated from the middle region of exon 2,
and a potential TATA-box sequence (indicated in bold capital letters) is
predicted at position  31 of the transcription initiation site. The black
bars indicate the positions of scl-a MO, scl-b MO, and scl-sp MO. The
white boxes represent sequences that encode the basic helix-loop-helix
domain.
doi:10.1371/journal.pbio.0050132.g001
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Author Summary
Hematopoiesis is the process that generates all the body’s blood
cells. In vertebrates, hematopoietic development occurs in two
phases: a transitory embryonic, or primitive, wave produces only
erythrocytes (red blood cells) and myeloid cells; an adult, or
definitive, wave gives rise to at least three blood cell lineages,
including erythrocytes and two types of immune cells—myeloid
cells and lymphocytes. Previous studies have shown that the stem-
cell leukemia (SCL) gene is essential for hematopoietic stem cell
specification and erythrocyte maturation. Yet how SCL regulates
these distinct processes is not fully understood. This study
demonstrates that zebrafish produce a smaller isoform of scl, scl-b,
that plays an overlapping role with the full-length scl-a in the
initiation of primitive hematopoiesis, but possesses distinct func-
tions in regulating primitive erythrocyte maturation and definitive
hematopoietic stem cell development. We further show that the
distinct functions of scl-a and -b are likely due to differences in their
protein expression level through the regulation of protein stability.
We postulate that hematopoietic cell development at different
levels of hierarchy is governed by a gradient of the Scl protein
created by temporal and spatial expression of different scl isoforms.analysis by Northern blot revealed that the expression of scl-b
began at the one- to two-somite stage, peaking at around the
11- to 18-somite stage, and maintained a lower level in the
adult kidney (Figure 1A). On the other hand, the scl-a
transcript was not detected until the four-somite stage, after
which it rapidly increased its level to that of scl-b,
subsequently becoming the dominant form in the adult
kidney (Figure 1A). Considering the fact that the scl-b
transcript initiates within the exon 2, where a potential
TATA-box sequence can be found at position  31 of the
predicted transcription initiation site (Figure 1B), and
expresses earlier than scl-a (Figure 1A), we conclude that scl-
b is generated from an alternative promoter site within exon
2 encoding a truncated Scl protein lacking the N-terminal
118 aa (Figure S1).
Temporal and Spatial Expression Patterns of scl-a and -b
WISH was performed to examine the temporal and spatial
expression of scl-a and -b. As shown in Figure 2, the 39-probe,
which recognized both scl-a and -b, exhibited a pattern
identical to that of scl expression described previously [34,35].
It ﬁrst emerged at around the two-somite stage as one pair of
stripes in the PLM followed by the appearance of a second
pair of stripes in the ALM at the four-somite stage (Figure 2A
and 2B). These two pairs of stripes, which represented the
combination of both scl-a and -b transcripts (referred to as scl-
a/b stripes hereafter), extended anteriorly and posteriorly
from the four-somite stage onwards (Figure 2B and 2C). And
by the 18-somite stage, the scl-a/b stripes were mainly
localized in three regions: the ALM, the anterior of the
PLM (APLM), and ICM (Figure 2D). In contrast to the 39-
probe-positive signals, the 59-probe-positive signals, which
represented only the full-length scl-a, appeared at the four-
and six-somite stage as two pairs of stripes (scl-a stripes) in the
PLM and ALM, respectively (Figure 2H, and data not shown).
By the 18-somite stage, the scl-a expression was restricted to
the ICM (Figure 2J), where primitive erythropoiesis actively
occurs at this stage [10], suggesting that scl-a is predominantly
expressed in the erythroid lineage from the 18-somite stage
onwards. This possibility was further supported by the lack of
scl-a expression in the erythrocyte-deﬁcient mon (trim33)
mutant embryos [36] (Figure 2F and 2L). Notably by 26 hpf,
only a weak signal of the 39- but not the 59-probe was detected
in the ventral wall of DA (Figure 2E and 2K), where the ﬁrst
deﬁnitive hematopoietic stem cells presumably emerge
[10,14,15], suggesting that scl-b is the main isoform expressed
in the deﬁnitive hematopoietic stem cells. To test this
possiblity, we carried out double staining analysis in which
26 hpf embryos were stained with anti-Scl-a (Ab-Scl-N) or
anti-Scl-a/b (Ab-Scl-C) antibodies together with c-myb WISH.
Figure 2. Distinct Expression Pattern of scl-a and -b during Early Embryonic Development
(A–L) Examination of scl-a and -b expression by WISH in wild-type and mon mutant embryos. WISH was performed in 2-somite (s) (A and G), 4-somite (B
and H), 8-somite (C and I), 18-somite (D and J), and 26-hpf (E and K) wild-type embryos, and 18-somite mon mutant embryos (F and L). The 39-probe (A–
F) detected the expression of both scl-a and -b, whereas the 59-probe (G–L) detected scl-a expression. The arrows indicate the expression of scl-b (E),
but not scl-a (K), in the ventral wall of DA. Embryos are in dorsal (A and G), flat-mounted dorsal (B, C, H, and I), and lateral (D–F and J–L) views with
anterior to the top (A and G) or the left (B–F and H–L).
(M–R) Transverse sections through the trunk region of 26-hpf wild-type embryos with dorsal up. Fluorescence in situ hybridization showed the
expression of c-myb in the ventral wall of DA (white arrowhead in [M, O, P, and R]). Immunochemistry staining showed that Ab-Scl-C (black arrowhead in
[N and O]) but not Ab-Scl-N (Q) detected Scl expression in the ventral wall of DA, demonstrating the co-localization of scl-b and c-myb in the ventral wall
of DA (O). NC, notochord; NT, neural tube; PCV, posterior cardinal vein.
(S) Schematic diagram in flat-mounted dorsal view to illustrate the temporal and spatial expression of scl-a and -b. Red represents scl-b expression,
whereas yellow indicates scl-a/b co-expression.
doi:10.1371/journal.pbio.0050132.g002
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embryos showed that Scl-b but not Scl-a protein was present
in the ventral wall of DA in a manner partially overlapping
with c-myb-positive cells (Figure 2M–2R), indicating that the
deﬁnitive hematopoietic stem cells predominantly express scl-
b. Based on these observations, we conclude (as illustrated in
Figure 2S) that scl-b appears ﬁrst and expresses in the entire
ALM and PLM regions; scl-a emerges later in the ALM and
ICM, possibly in a manner overlapping with scl-b, and is
subsequently restricted to the ICM by the 18-somite stage.
Notably, only scl-b expresses in the ventral wall of DA where
the ﬁrst deﬁnitive hematopoietic stem cells arise.
Redundant Roles for scl-a and -b in the Initiation of
Primitive Hematopoiesis
To determine the biological functions of scl-a and -b in
hematopoiesis, two MOs, scl-a MO and scl-b MO (Figure 1B),
that speciﬁcally inhibited the protein syntheses of scl-a and -b,
respectively, were injected into wild-type zebraﬁsh embryos.
Immunohistochemistry staining showed that scl-a MO and -b
MOspeciﬁcallyabolishedtheScl-a and -b proteinexpressionas
indicated by lack of anti-Scl-N staining in the ICM of scl-a
morphants (Figure 3N, n¼35/35), and the selective loss of anti-
Scl-C staining in the APLM (where only scl-b was transcribed
[Figure 2D]) of scl-b morphants (Figure 3S, n ¼ 32/32).
Microscopic analysis of the 24-hpf embryos injected with either
MO revealed no obvious abnormality in general morphology
(data not shown). Examination of the expression of gata1
(Figure 3A, n¼46/46; 3B, n¼43/43; and 3C, n¼41/41), be1-globin
(hbbe1) (Figure3E,n¼49/49;3F,n¼51/51;and3G,n¼49/49),and
pu.1 (spi1) (Figure3I,n¼41/41;3J,n¼41/43;and3K,n¼45/45) by
WISH conﬁrmed that the initiation of primitive erythropoiesis
and myelopoiesis were intact in the scl-a and -b morphants. We
reasoned that the lack of phenotypes in both morphants was
likely due to the functional redundancy of scl-a and -b. To test
this possibility, we co-injected scl-a MO and scl-b MO to block
both protein syntheses (Figure 3P, n¼45/45; and 3T, n¼50/50),
and found that the expression of gata1, be1-globin, and pu.1 were
either absent or drastically reduced in the co-injected
morphants (Figure 3D, n ¼ 42/42; 3H, 46/46; and 3L, n ¼ 47/
47). This phenotype is very similar to that found in the scl-sp
morphants, in which both Scl-a and -b protein expression were
eliminated by scl-sp MO (Figure 1B) that interfered with the
splicing between exon 2 and 3 of the scl gene [37,38].
Furthermore, injection of in vitro synthesized scl-a or -b mRNA
was sufﬁcient to rescue the expression of gata1, be1-globin, and
pu.1 in the scl-sp morphants (data not shown). Taken together,
we conclude from these results that scl-a and -b are functionally
redundant in the initiation of primitive hematopoiesis.
scl-a and -b Play Distinct Roles in Primitive Red Blood Cell
Differentiation
To address their functions in the late developmental stages
of primitive erythropoiesis, we examined the scl-a and -b
Figure 3. scl-a and -b Are Functionally Redundant in the Initiation of Primitive Hematopoiesis
(A–L) WISH of gata1 (A–D), be1-globin (E–H), and pu.1 (I–L). Similar expression of gata1, be1-globin, and pu.1 were detected in 20-hpf control embryos (A,
E, and I), scl-a morphants (B, F, and J), and scl-b morphants (C, G, and K). In contrast, expression of gata1, be1-globin, and pu.1 were significantly reduced
or absent in scl-a/b co-injected morphants (D, H, and L). All embryos are in lateral view with anterior to the left.
(M–T) Immunohistochemistry staining of endogenous Scl proteins in 20-hpf control embryos (M and Q) and scl-a (N and R), scl-b (O and S), and scl-a/b
co-injected (P and T) morphants using Ab-Scl-N (M–P) and Ab-Scl-C (Q–T). In scl-a morphants, the Ab-Scl-N (N), but not Ab-Scl-C (R), staining in the ICM
was absent, showing that scl-a MO specifically blocks the translation of scl-a. In the scl-b morphants, the Ab-Scl-C staining was selectively abolished in
the APLM, where only scl-b is transcribed ([S] asterisk, inset), demonstrating that scl-b MO specifically blocks the protein expression of scl-b. In the scl-a/
b co-injected morphants, neither Ab-Scl-N nor Ab-Scl-C staining was detected (P and T). Insets in (Q–T) are dorsal views of the magnified APLM marked
by asterisks. Embryos are in lateral view with anterior to the left.
doi:10.1371/journal.pbio.0050132.g003
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initiated normally, o-dianisidine staining revealed that the
red blood cells (RBCs) in the scl-b morphants were signiﬁ-
cantly reduced by 2 dpf (data not shown) and ﬁnally not
detectable by 3 dpf (Figure 4C). On the other hand, RBCs in
the scl-a morphants were normal before 3 dpf (Figure 4B) but
began to decrease by 4 dpf (data not shown) and were severely
reduced by 5 dpf (Figure 4E). These data indicate that the loss
of either Scl-a or -b protein renders abnormal RBC differ-
entiation at different developmental stages, eventually
resulting in anemia. To provide an additional test of this
possibility, circulating RBCs were collected from the scl-a and
-b morphants, stained with May-Grunwald Giemsa, and
compared to those from wild-type embryos. Based on the
size of cell, shape of nucleus, and staining of cytoplasm,
normal primitive RBCs from 30 hpf to 5 dpf can be classiﬁed
into four main stages: stage I, basophilic erythroblast; stage II,
polychromatophilic erythroblast; stage III, orthochromato-
philic erythroblast; and stage IV, mature erythrocyte (Figure
4G). In the 2-dpf wild-type embryos and 2-dpf scl-a
morphants, more than 98% of the circulating RBCs were at
stage II (Figure 4H and 4I). However, 90% of the circulating
RBCs arrested at stage I in the 2-dpf scl-b morphants (Figure
4J). As expected, although the circulating RBCs developed
normally before 3 dpf, 80% of them were blocked at stage II
in the 4-dpf scl-a morphants (Figure 4L), compared to the
number of RBCs at stage III in the 4-dpf wild-type embryos
(Figure 4K). These phenotypes concurred with the virtual
Northern blot result showing that circulating RBCs from 30-
hpf wild-type embryos contain both scl-a and -b, whereas
those from 2-dpf wild-type embryos express predominantly
scl-a (Figure 5). Collectively, we conclude that scl-b plays a
critical role in the differentiation of basophilic erythroblasts
to polychromatophilic erythroblasts, whereas scl-a is pivotal
for the transition from polychromatophilic erythroblasts to
orthochromatophilic erythroblasts.
Figure 4. Requirement of scl-a and -b at Different Development Stages of Primitive RBC Differentiation
(A–F) O-dianisidine staining of hemoglobin. At 3 dpf, expression of hemoglobin was severely reduced in scl-b morphants (C) compared to control
embryos (A) and scl-a morphants (B). At 5 dpf, the o-dianisidine staining in both scl-a (E) and scl-b (F) morphants was dramatically decreased compared
to that in control embryos (D). All embryos are in lateral view with anterior to the left.
(G–L) May-Grunwald Giemsa staining of RBCs of different developmental stages (30 hpf to 5 dpf). Normal primitive RBCs at 30 hpf to 5 dpf can be
classified into four main developmental stages (G): stage I, basophilic erythroblast; stage II, polychromatophilic erythroblast; stage III,
orthochromatophilic erythroblast; and stage IV, mature erythrocyte. While RBCs from 2-dpf control embryos (H) and scl-a morphants (I) have
differentiated into the polychromatophilic erythroblast stage (stage II), RBCs from scl-b morphants (J) are halted at the earlier basophilic erythroblast
stage (stage I). At 4 dpf, RBCs from scl-a morphants (L) are arrested at stage II, while there is normal development of stage IV RBCs in control embryos
(K). Scale bar (G–L), 10 lm.
doi:10.1371/journal.pbio.0050132.g004
Figure 5. The scl-a and -b Transcripts in 30-hpf and 2-dpf Embryos and
RBCs
Virtual Northern blotting shows that 30-hpf RBCs express both scl-a and -
b (lane 2) whereas 2-dpf RBCs express predominantly scl-a (lane 4).
doi:10.1371/journal.pbio.0050132.g005
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Requires scl-b but Not -a
We next explored the roles of the scl-b and -a isoforms in
deﬁnitive hematopoiesis. In zebraﬁsh, deﬁnitive hemato-
poietic stem cells originate from the ventral wall of DA at
around 26 hpf to 30 hpf, and these cells are enriched in c-myb
and runx1 expression [10,14,15]. We therefore ﬁrst examined
c-myb and runx1 expression in the 30-hpf scl-a and -b
morphants. WISH revealed that expression of c-myb and
runx1 in the ventral wall of DA was abolished in the scl-b
morphants (Figure 6C, n¼43/45; and 6F, n¼40/43) but not in
the control embryos (Figure 6A, n ¼40/40; and 6D, n ¼ 42/42)
or scl-a morphants (Figure 6B, n¼45/46; and 6E, n¼43/45). As
artery endothelial cells appeared to be retained in both scl-a
and -b morphants, as indicated by two artery-speciﬁc markers
deltaC (dlc) and grl (hey2) (Figure S2), these data indicate that
scl-b, but not -a, is essential for deﬁnitive hematopoietic stem
cell development. This result is consistent with the ﬁnding
that only scl-b is expressed in the ventral wall of DA (Figure 2).
To further test whether scl-b is indeed required for the
development of deﬁnitive hematopoietic stem cells, we
investigated T cell development in both morphants by
examining rag1 expression at 5 dpf. As expected, rag1 was
detected in the thymus of control embryos and scl-a
morphants (Figure 6G, n ¼ 30/30; and 6H, n ¼ 42/45) but not
scl-b morphants (Figure 6I, n ¼ 46/50). Taken together, these
data demonstrate that scl-b is essential for the development of
deﬁnitive hematopoietic stem cells while scl-a is dispensable.
Differences in the Protein Expression Level of Scl-a and -b
Give Rise to Their Distinct Functions
To gain insight into the molecular basis underlying the
distinct functions of scl-a and -b in hematopoietic cell
development, we performed rescue experiments—by co-
injecting in vitro synthesized scl-a or scl-b mRNA with scl-sp
MO into wild-type embryos—to test whether the lack of the N-
terminal 118 aa could lead to the differences in their
biological functions. Examination of the expression of be1-
globin and c-myb by WISH showed that either isoform was
sufﬁcient to rescue both primitive and deﬁnitive hemato-
poietic defects in the scl-sp morphants (Figure 7A, n ¼ 35/35;
7B, n¼41/41; 7C, n¼44/44; 7D, n¼47/47; 7E, n¼36/36; 7F, n¼
40/45; 7G, n¼41/45; and 7H, n¼42/46). The data indicate that
the N-terminal 118-aa segment is not essential for determi-
nation of the functions of these two Scl protein isoforms,
consistent with previous ﬁndings showing that the basic helix-
loop-helix domain of the murine SCL protein is sufﬁcient for
hematopoiesis [39]. As recent studies have suggested that
different SCL protein expression levels are required at
different levels of hematopoietic hierarchy [40,41], these
ﬁndings raise the possibility that the distinct functions of scl-
a and -b are due to differences in their protein expression
levels, resulting in establishment of a gradient of Scl protein at
different stages of hematopoietic hierarchy. To test this
hypothesis, we performed immunoblotting of protein extracts
from 18-somite-stage wild-type embryos, in which the tran-
scription levels of the scl-a and -b isoforms are similar (the scl-b
RNA is slightly higher) (Figure 1A). We found that the protein
expression level of Scl-b was much lower than that of Scl-a in
theseembryos (the Scl-b protein was hardly detectable at all by
Western blot; Figure 7I). When COS7 cells were transiently
transfected with construct expressing either the full-length scl-
a or scl-b, the protein expression level of Scl-b was also much
lower than that of Scl-a, while their RNA levels were
comparable (Figure 7J). These data strongly indicate that a
post-transcriptional mechanism is involved in the regulation
of Scl-b protein expression level. To test this, equal amounts
of in vitro synthesized scl-a and -b mRNA were injected into
one-cell-stage wild-type embryos, and protein levels were
examined at different time points post-injection (Figure 7K).
As anticipated, real-time reverse transcriptase PCR analysis
revealed that mRNAs of both isoforms behaved similarly in
these injected embryos (data not shown). Immunoblotting of
whole embryo protein extracts showed that protein expres-
Figure 6. Specification of Definitive Hematopoietic Stem Cells Requires scl-b but Not scl-a
(A–F) WISH of definitive hematopoietic stem cell markers c-myb (A–C) and runx1 (D–F). Expression of c-myb and runx1 in the ventral wall of DA was
markedly reduced in 30-hpf scl-b morphants (C and F) but not in 30-hpf control embryos (A and D) or scl-a morphants (B and E). Insets are high-
magnification (203) views of the ventral wall of DA. The arrowheads indicate the definitive hematopoietic stem cells along the ventral wall of DA.
(G–I) WISH of T cell marker rag1. rag1 expression in thymic T cells was abolished in 5-dpf scl-b morphants (I) but not in control embryos (G) and scl-a
morphants (H). Arrows indicate the thymus region.
In all panels, embryos are in lateral view with anterior to the left.
doi:10.1371/journal.pbio.0050132.g006
PLoS Biology | www.plosbiology.org May 2007 | Volume 5 | Issue 5 | e132 1115
scl Isoforms in Zebrafish Hematopoiesission levels were comparable at 3 h post-injection, indicating
that both isoforms are effectively translated. However, by 4 h
post-injection, Scl-b protein level was greatly reduced, while
Scl-a level increased (Figure 7K), showing that the low protein
expression level of Scl-b was likely due to the rapid
degradation of its protein. Taken together, these data strongly
indicate that differences in the protein expression levels of
Scl-a and -b isoforms, via regulation of their protein
stabilities, likely confer their distinct functions in the
regulation of hematopoietic cell development.
Discussion
It is believed that the complexity in morphology and
behavior of higher organism is achieved not only by higher
gene numbers, but also by multiple protein isoforms being
encoded by a single gene locus and by the complexity of
protein–protein interactions. The most well studied phenom-
enon that results in the generation of multiple protein
isoforms from a single gene is alternative splicing of pre-
mRNA [42]. However, other mechanisms such as use of an
alternative promoter—a phenomenon that is as equally
widespread in higher organisms as alternative pre-mRNA
splicing [43,44]—are less appreciated. In this article, we
described how zebraﬁsh produce, through alternative pro-
moter sites, two scl isoforms, the full-length scl-a and a novel
truncated scl-b (Figure 1). We further showed that these two
scl isoforms manifest distinct temporal and spatial expression
(Figure 2) and exert distinct functions in the regulation of
primitive and deﬁnitive hematopoiesis (Figures 3–6). The
Figure 7. Differences in Protein Expression Levels of Scl-a and -b Confer Their Distinct Functions
(A–H) be1-globin and c-myb expression in scl-sp morphants is rescued by scl-a and -b mRNA. (A–D) show WISH of be1-globin in 20-hpf control embryos
(A), scl-sp morphants (B), scl-sp morphants injected with scl-a mRNA (C), and scl-sp morphants injected with scl-b mRNA (D). (E–H) show WISH of c-myb
in 30-hpf control embryos (E), scl-sp morphants (F), scl-sp morphants injected with scl-a mRNA (G), and scl-sp morphants injected with scl-b mRNA (H).
Insets in (E–H) are high-magnification (203) views of the ventral wall of DA, indicated by black arrowhead. In all panels, embryos are in lateral view with
anterior to the left.
(I) Immunoblotting with Ab-Scl-C antiserum shows the expression levels of Scl-a and Scl-b proteins in wild-type (wt) embryos, clo mutant embryos, and
scl-a morphants. Although Scl-b protein was not detectable, immunoblotting of whole embryo protein extracts (50 lg for each sample) showed that
Scl-a protein expression increased as embryos developed from the 18-somite (lane 1) to 22-somite (lane 4) stage. The clo mutant embryos (lane 3) and
scl-a morphants (lane 2), in which Scl-a protein was not detected, were used as the controls to distinguish the Scl-a protein (arrow) and nonspecific
band (asterisk).
(J) Immunoblotting with Ab-Scl-C antiserum shows the expression levels of Scl-a and Scl-b proteins in transfected COS7 cells. Western blotting of whole
cell protein extracts (10 lg for each sample) prepared from COS7 cells transfected with full-length scl-a, scl-b, or blank vector constructs revealed that
the protein level of Scl-a was much higher than that of Scl-b. RT-PCR analysis (bottom) showed similar RNA levels of scl-a and -b in these transfected
cells. Tubulin and GAPDH were used as controls for Western blot and PCR, respectively.
(K)Immunoblotting withAb-Scl-Cantiserum showstheexpressionlevels of Scl-a andScl-b proteins in the embryosinjected within vitro synthesized scl-a
or -b mRNA. Western blotting of whole embryo protein extracts (50 lg for each sample) from embryos injected with 500 pg of scl-a or -b mRNA showed
that, at 3 h post-injection, the Scl-b protein was detected as being at a comparable level to that of Scl-a but dramatically reduced by 4 h post-injection.
doi:10.1371/journal.pbio.0050132.g007
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isoform in zebraﬁsh has not only revealed new insight into
the roles of scl in the regulation of hematopoietic cell
development, but also provided another example to highlight
the importance of alternative promoter usage in generating
protein and regulatory diversity.
Previous studies have revealed that mammals contain
several SCL isoforms generated by either alternative splicing,
alternative promoters, or alternative translation initiation
sites [28–33]. These mammalian SCL isoforms arise from
alternative promoters in exon 1a and exon 1b, and encode
identical proteins, the full-length SCL. In contrast, scl-b in
zebraﬁsh is generated through an alternative promoter site
within the scl exon 2, the equivalent of the mammalian SCL
exon 4, and encodes an N-terminal truncated protein
(Figures 1 and S1). Thus, scl-b is clearly distinct from the
previously described mammalian SCL isoforms. One intrigu-
ing question raised is whether the mechanism of generating
different scl isoforms found in zebraﬁsh is evolutionarily
conserved in higher vertebrates, especially in mammals.
Considering the facts that (1) the SCL locus is highly
conserved in vertebrates [45], (2) there are observations
showing that the murine SCL exon 4 has promoter activity in
the context of SCL 39 stem cell enhancer [46], and (3) a
truncated SCL transcript initiated from exon 4 can be
detected in some of the human T cell leukemia cell lines
[28,29], we speculate that a scl-b equivalent may exist in higher
vertebrate species.
Another interesting issue raised by this study is the
regulation of scl-a and -b transcripts during hematopoiesis.
Notably, scl-b ﬁrst appears in hematopoietic stem and
progenitor cells and soon diminishes in the differentiated
primitive RBCs (Figures 2 and 5). In contrast, scl-a emerges
later and is predominantly restricted to RBCs (Figures 2 and
5). Thus, it appears that an on–off switch, from scl-b to -a
expression, must occur during primitive RBC development.
Considering the facts that (1) the earliest deﬁnitive hema-
topoietic stem/progenitor cells located in the ventral wall of
DA express only scl-b and (2) scl-a becomes the predominant
isoform expressed in the adult kidney marrow, where
deﬁnitive hematopoiesis takes place presumably from 5 dpf
onwards in zebraﬁsh development, it is conceivable to
speculate that this on–off switch may also exist during
deﬁnitive erythroid cell development. However, it is unclear
at this moment whether this on–off switch takes place at the
transcriptional level or the post-transcriptional level, or
perhaps a combination of both. Nevertheless, we believe that
the on–off switch of these scl isoforms must play a crucial role
in normal hematopoietic cell development, at least for RBCs,
and that the underlying molecular basis of this regulation
warrants further studies.
Our study has provided evidence indicating that differ-
ences in the protein expression levels of the scl-a and -b
isoforms are likely to confer their distinct functions in
regulating hematopoietic cell development (Figure 7).
Although we cannot rule out the possibility that translational
control may contribute to the regulation of their protein
expression levels, the fact that the Scl-b protein was initially
expressed at a level comparable to that of Scl-a but soon
reduced dramatically upon injection of equal amounts of in
vitro synthesized scl-a and -b mRNA (Figure 7K) strongly
indicates that differences in the protein expression levels of
the scl-a and -b isoforms are largely due to the rapid turnover
of the Scl-b protein. However, the triggers causing the onset
of rapid degradation of Scl-b protein in vivo are unclear.
Given the differences in their N-terminal residues, one could
speculate that, perhaps, the short half-life of the Scl-b protein
is mediated through the N-end rule degradation, a common
proteolytic pathway that is present in prokaryotes, fungi,
plants, and animals [47]. Further biochemical analyses are
required to clarify this issue.
Finally, our data strongly suggest that the establishment of
an appropriate Scl protein gradient at different levels of
hematopoietic hierarchy—a low level in hematopoietic stem
and progenitor cells and a high level in differentiated RBCs—
is essential for hematopoietic cell development. The phe-
nomenon of a lower Scl protein level in hematopoietic stem
and progenitor cells correlating to the importance of
hematopoietic cell development is intriguing. One possibility
is that the speciﬁcation of deﬁnitive stem and progenitor cells
requires the low concentration of Scl protein, which occurs
by preferential expression of scl-b during early hematopoiesis.
However, the fact that injection of either scl-a or -b mRNA is
sufﬁcient to rescue the c-myb expression at 30 hpf in the
ventral wall of DA in scl-sp morphants (Figure 7) suggests that
this may not be the case. A high Scl protein level, which is
known to be required for the maturation of RBCs [40,41], has
the tendency to promote hematopoietic stem and progenitor
cell differentiation into erythroid lineage, so a more likely
explanation is that the low concentration of the Scl-b protein
ensures the proper expansion of these cell pools by
promoting their proliferation rather than their differentia-
tion. In addition, the low concentration of Scl-b may also be
crucial for maintaining an unbiased differentiation potential
of hematopoietic stem and progenitor cells during ontogeny.
Uncovering the molecular basis of scl-a- and -b-mediated
actions will provide further insight into our understanding of
the speciﬁcation, proliferation, and differentiation of hem-
atopoietic lineages.
Materials and Methods
Zebraﬁsh. Zebraﬁsh were maintained at 27 to 28 8C as described in
[48]. The clo
s5 and mon
tg234 mutants were kindly provided by Didier Y.
R. Stainier (University of California San Francisco, United States) and
Artemis Pharmaceuticals (Germany), respectively.
scl plasmid constructs. The full-length scl-a and -b DNA were
ampliﬁed by RT-PCR and cloned into pCS2þ vector. The scl-59 and
scl-39 constructs contained the ﬁrst 414 bp of the 59 UTR of scl-a and
the last 539 bp of the 39 UTR of scl-a/b, respectively. They were
ampliﬁed by PCR using two sets of speciﬁc primers (scl-59:5 9-
acttcagtgcatctaaaacctcag-39/59-ttttatatccgcgctccctcctc-39; scl-39:5 9-
tggaaattcaagcgggtaatgac-39/59-gggcttttcatataaaatttgtgag-39) and subcl-
oned into pGEM-T Easy and pGEM-T vector (Promega, http://www.
promega.com).
59 and 39 RACE. Total RNA was extracted from wild-type embryos
and subjected to 59 and 39 RACE using the SMART RACE cDNA
Ampliﬁcation Kit (Clontech, http://www.clontech.com) according to
the manufacturer’s instructions. For 59 and 39 RACE, two sets of
primers (scl-59-P1: 59-aagttgatgtacttcatggccag-39; scl-59-P2: 59-atacatcc-
catactgttccgcatctccagc-39; scl-39-P1: 59-gcggaacagtatgggatgtatcct-39;
scl-39-P2: 59-ctagtgcgggacgacctc-39) were used. The RACE products
were cloned into pGEM-T Easy vector (Promega) and subsequently
sequenced.
Sequence alignment analysis. The T-Coffee method [49] was used
for protein sequence alignment.
Northern and virtual Northern blot. Total RNA from different
stages of embryos, adult kidney, and RBCs were prepared using the
RNeasy Kit (Qiagen, http://www.qiagen.com) according to the
manufacturer’s instructions. mRNA was puriﬁed using the Nucleo-
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com) according to the manufacturer’s instructions. Three micro-
grams of each embryonic mRNA and 30 lg of total kidney RNA were
used for Northern blot analysis (Figure 1A). For virtual Northern blot,
total RNA from 30-hpf and 2-dpf embryos and RBCs were reverse
transcribed into cDNA and then ampliﬁed by the SMART PCR
cDNA synthesis kit (Clontech). The ampliﬁed cDNAs were used as
targets for hybridization with the DIG-labeled scl-59 and scl-39 probes.
DIG labeling was carried out by PCR ampliﬁcation with the DIG
Probe Synthesis Kit (Roche Applied Science, http://www.
roche-applied-science.com) according to the manufacturer’s instruc-
tions. Northern blot and virtual Northern blot analyses were
performed as previously described [50,51].
O-dianisidine staining. Fish embryos were stained for 15 min in the
dark in o-dianisidine staining solution as previously described [12].
Whole-mount in situ hybridization. Generation of the DIG-labeled
anti-sense RNA probes and whole-mount in situ hybridization were
performed as described in [48]. For transverse cryosection, embryos
were embedded in OCT solution (Sakura, http://www.sakura.com)
after WISH and immunochemistry staining. Embedded embryos were
sectioned at a thickness of 10 lm using a Leica (http://www.leica.com)
microtome. The sections were mounted on glass slides and imaged
using a Zeiss (http://www.zeiss.com) AxioPhot 2 imaging system.
Immunohistochemistry analysis. Anti-zebraﬁsh Scl-a N-terminal
(aa 17 to 62, referred to as Ab-Scl-N) and Scl-a/b C-terminal (aa 255 to
325, referred to as Ab-Scl-C) antisera were generated by immunizing
rabbits with the GST-Scl-N and GST-Scl-C fusion proteins using
standard protocol. Antibody puriﬁcation and immunohistochemistry
staining were carried out as previously described [52].
MO injection. Anti-sense MOs (Gene Tools) were designed as
follows: scl-a MO, 59-gctcggatttcagtttttccatcat-39; scl-b MO, 59-gcggact-
caactgcaccattcgagt-39; scl-sp MO, 59-agatttaaaatgctcttaccatcgt-39.
Three nanograms of scl-a MO, 8 ng of scl-b MO, and 8 ng of scl-sp
MO mixed with phenol red were separately injected into wild-type
embryos at the one-cell stage. Similarly, 3 ng of scl-a MO and 8 ng of
scl-b MO were used for the co-injection experiment. Wild-type
embryos injected with a mixture of sterile water and phenol red were
used as control.
May-Grunwald Giemsa staining of embryonic RBCs. Fish embryos
were anesthetized in calcium- and magnesium-free PBS (pH 7.4)
containing 0.02% tricaine (Sigma-Aldrich, http://www.sigmaaldrich.
com) and 1% BSA (Sigma-Aldrich). After tail clipping using surgical
scissors, blood cells were collected by pipetting and cytospun onto
slides by centrifugation at 450 rpm for 3 min using a Cytospin 4
(Thermo Scientiﬁc, http://www.thermo.com). The slides were then air-
dried and subjected to May-Grunwald Giemsa staining according to
the standard protocol.
In vitro RNA synthesis and micro-injection. In vitro transcription
was carried out using the mMESSAGE mMACHINE sp6 kit (Ambion,
http://www.ambion.com) accordingto themanufacturer’s instructions.
For rescue experiments, 200 pg of scl-a or -b RNA was co-injected with
8n go fscl-sp MO into wild-type embryos at the one-cell stage.
Protein stability analysis. For protein stability analysis in ﬁsh
embryos, 500 pg of in vitro synthesized scl-a or -b mRNA was injected
into embryos at the one-cell stage, and protein extracts were
prepared as described in [48]. Total RNA from both scl-a- and -b-
injected embryos at 6 h post-injection were extracted and reverse
transcribed using random hexamer as primer. The cDNAs were
examined with real-time PCR using scl-speciﬁc primers (scl-961F, 59-
ctagtgcgggacgacctc-39; scl-1528R, 59-ggaactaaactgtgccga-39), which
can amplify both injected scl-a and -b mRNA. COS7 cells were
maintained in DMEM (Gibco, http://www.invitrogen.com/content.
cfm?pageid¼11040) supplemented with 10% bovine calf serum
(Hyclone, http://www.hyclone.com). Transient transfection was car-
ried out by SuperFect Reagent (Qiagen) according to the manufac-
turer’s protocol. Real-time RT-PCR was performed to ensure that the
transfection efﬁciency was similar using the same RT-PCR protocol
for protein stability analysis in ﬁsh embryos. Cell extract preparation
and Western blot were carried out as described previously [50].
Supporting Information
Figure S1. Sequence Alignment of Zebraﬁsh Scl-a/b and Human and
Mouse Full-Length SCL Proteins
The full-length scl-a encodes a protein of 324 aa, whereas scl-b
encodes a truncated protein lacking the N-terminal 118 aa. The
predicted translation start site (indicated by arrow) of scl-b is
conserved between zebraﬁsh, human, and mouse. The basic helix-
loop-helix domain is highlighted in red.
Found at doi:10.1371/journal.pbio.0050132.sg001 (33 KB DOC).
Figure S2. The Artery Endothelial Cells Are Retained in Both scl-a
and -b Morphants
WISH of artery-speciﬁc markers deltaC ([A], n ¼ 42/42; [B], n ¼ 41/44;
and [C], n¼45/46) and grl ([D], n¼40/40; [E], n¼45/46; and [F], n¼44/
47). At 24 hpf, expression of deltaC and grl was only slightly reduced in
both scl-a ([B and E], arrowheads) and -b morphants ([C and F],
arrowheads) when compared to the control embryos ([A and D],
arrowheads).
Found at doi:10.1371/journal.pbio.0050132.sg002 (5.0 MB TIF).
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